NYSEARCA:CTEK - NYSE Arca - US23258P1057 - Common Stock - Currency: USD
1.25
+0.02 (+1.63%)
The current stock price of CTEK is 1.25 USD. In the past month the price increased by 4.17%. In the past year, price decreased by -36.55%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
CI | THE CIGNA GROUP | 11.44 | 85.67B | ||
CVS | CVS HEALTH CORP | 9.56 | 76.79B | ||
LH | LABCORP HOLDINGS INC | 16.47 | 20.30B | ||
DGX | QUEST DIAGNOSTICS INC | 18.63 | 19.12B | ||
FMS | FRESENIUS MEDICAL CARE-ADR | 18.25 | 17.03B | ||
BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 129.69 | 14.08B | ||
HIMS | HIMS & HERS HEALTH INC | 79.46 | 12.26B | ||
DVA | DAVITA INC | 14.96 | 10.62B | ||
CHE | CHEMED CORP | 24.17 | 8.33B | ||
CRVL | CORVEL CORP | 26.4 | 5.67B | ||
OPCH | OPTION CARE HEALTH INC | 25.33 | 5.14B | ||
GH | GUARDANT HEALTH INC | N/A | 4.71B |
CynergisTek, Inc. engages in the provision of cybersecurity, privacy, and compliance services for companies. The company is headquartered in Austin, Texas and currently employs 89 full-time employees. The company went IPO on 2017-02-14. The firm is engaged in the business of providing companies with cybersecurity, privacy and compliance services through its assessment and technical testing, remediation, management, and validation services. The company serves companies in regulated industries, including healthcare, higher education, technology, government, manufacturing, and the financial sector through the CynergisTek, Backbone Consulting and Redspin brands. Its services are categorized into four service groups, which include Assess, Build, Manage, and Validate. The Assess service identifies, measures, and test security and privacy risk of an organization’s readiness and verify and validate programs through information technology audits, technical testing, and risk and program assessments. The Build service develops policies and procedures and playbooks to help build out a range of risk management programs.
CYNERGISTEK INC/DE
11940 Jollyville Road, Suite 300-N
Austin TEXAS 78759 US
CEO: Caleb Barlow
Employees: 89
Phone: 19496140700.0
The current stock price of CTEK is 1.25 USD. The price increased by 1.63% in the last trading session.
The exchange symbol of CYNERGISTEK INC/DE is CTEK and it is listed on the NYSE Arca exchange.
CTEK stock is listed on the NYSE Arca exchange.
6 analysts have analysed CTEK and the average price target is 1.27 USD. This implies a price increase of 2% is expected in the next year compared to the current price of 1.25. Check the CYNERGISTEK INC/DE stock analysts ratings, price target forecast and up-and down grades for more detailed information.
CYNERGISTEK INC/DE (CTEK) has a market capitalization of 16.57M USD. This makes CTEK a Nano Cap stock.
CYNERGISTEK INC/DE (CTEK) currently has 89 employees.
CYNERGISTEK INC/DE (CTEK) has a support level at 1.24 and a resistance level at 1.27. Check the full technical report for a detailed analysis of CTEK support and resistance levels.
The Revenue of CYNERGISTEK INC/DE (CTEK) is expected to grow by 16.51% in the next year. Check the estimates tab for more information on the CTEK EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
CTEK does not pay a dividend.
CYNERGISTEK INC/DE (CTEK) will report earnings on 2022-11-09.
CYNERGISTEK INC/DE (CTEK) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.29).
ChartMill assigns a technical rating of 6 / 10 to CTEK. When comparing the yearly performance of all stocks, CTEK is a bad performer in the overall market: 69.77% of all stocks are doing better.
ChartMill assigns a fundamental rating of 3 / 10 to CTEK. CTEK scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
Over the last trailing twelve months CTEK reported a non-GAAP Earnings per Share(EPS) of -0.29. The EPS decreased by -52.63% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | -61.88% | ||
ROA | -55.8% | ||
ROE | N/A | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 43% to CTEK. The Buy consensus is the average rating of analysts ratings from 6 analysts.
For the next year, analysts expect an EPS growth of -23.1% and a revenue growth 16.51% for CTEK